In March 2025, the company introduced new designs to get a direct-to-purchaser presenting of its Wegovy weight loss drug. The company established a new pharmacy, identified as NovoCare, which would cost clients $499 every month for entry to the drug, below 50 % the expense of the drug by means of other pharmaceutical distribution networks.[53]A wei